The emerging approach of the medication represents a exciting advance in the management of type 2 diabetes. Unlike existing drugs, tirzepatide targets multiple pathways – the GLP-1 hormone and GIP – providing https://tirzepatidepeptide768164.blog-ezine.com/42606463/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment